Oxford's COVID-19 vaccine shows strong immune response in older people
Published
COVID-19 vaccine being developed by British-Swedish pharmaceutical firm AstraZeneca and Oxford University produced a strong immune response in older adults, raising hopes that it can protect the age groups most at risk from the virus.
The study, published in The Lancet medical journal, suggest that those aged over 70 -- who...